SXTC (SXTC) Stock Price & Analysis
SXTC (SXTC) fell 80.82% to USD 0.06 as of July 25, 2026 at 05:26 UTC, according to Nexqual real-time market data.
SXTC last closed at USD 0.33; the session ranged USD 0.05–0.27 on volume of 287,489,414 shares. Market capitalization is $2.44M, with a 52-week range of USD 0.05–1,047 (NCM). Source: Nexqual, July 25, 2026 at 05:26 UTC.
Key Statistics (as of July 25, 2026 at 05:26 UTC)
| Price | USD 0.06 |
|---|---|
| Change | ▼ 80.82% (down) |
| Previous Close | USD 0.33 |
| Open | USD 0.27 |
| Day Range | USD 0.05 – 0.27 |
| 52-Week Range | USD 0.05 – 1,047 |
| Volume | 287,489,414 shares |
| Market Cap | $2.44M |
| Exchange | NCM |
Technical Analysis (SXTC)
Nexqual's technical model rates SXTC "SELL" based on 3 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 05:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 23.48 (oversold) |
| vs SMA50 | Below (USD 2) |
| MACD | -0.25 (negative) |
Analyst Ratings (SXTC)
Wall Street analysts rate SXTC "None", per Nexqual as of July 25, 2026 at 05:26 UTC.
| Consensus Rating | None |
|---|
Earnings (SXTC)
Source: Nexqual, July 25, 2026 at 05:26 UTC.
Financials & Fundamentals (SXTC)
| Total Revenue | $1.14M |
|---|---|
| Revenue Growth (YoY) | -43.90% |
| Gross Margin | +21.85% |
| Operating Margin | -153.28% |
| Profit Margin | +0.00% |
| ROE | -27.49% |
| Debt / Equity | 3.77 |
| Current Ratio | 7.94 |
| Total Cash | $28.32M |
| Total Debt | $1.12M |
| Free Cash Flow | $-4.74M |
Source: Nexqual, July 25, 2026 at 05:26 UTC.
Financial Health Score (SXTC)
Nexqual rates SXTC's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 05:26 UTC.
| Growth | Critical — Revenue -44% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $28M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Critical — ROE -27%, ROA -15.8% |
Ownership (SXTC)
| Insider Ownership | +109.48% |
|---|---|
| Institutional Ownership | +0.24% |
| Shares Outstanding | 38.22M |
| Float | 31.94M |
| Short % of Float | +0.14% |
Source: Nexqual, July 25, 2026 at 05:26 UTC.
Leadership (SXTC)
SXTC is led by Feng Zhou (age 33), Chairman of the Board & Co-CEO, per Nexqual as of July 25, 2026 at 05:26 UTC.
| Chairman of the Board & Co-CEO | Feng Zhou (age 33) |
|---|---|
| Chief Financial Officer | Xiaodong Pan (age 48) |
| Executive Director | Jun Zheng (age 49) |
Major Backers & Investors (SXTC)
Notable institutional backers of SXTC include Sabby Management, LLC, according to Nexqual as of July 25, 2026 at 05:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sabby Management, LLC | 8.16% |
Source: Nexqual, July 25, 2026 at 05:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RETO | ReTo Eco-Solutions, Inc. | USD 2.74 | ▼ 2.49% |
| AIHS | Senmiao Technology Limited | USD 1.33 | ▼ 6.34% |
| BIMI | BIMI International Medical Inc. | USD 0 | ▲ 0% |
| ADTX | Aditxt, Inc. | USD 0 | ▲ 33.33% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.04 | ▼ 1.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 05:26 UTC. This page is informational and not investment advice.